• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆生物标志物与囊性纤维化肺病

Plasma biomarkers and cystic fibrosis lung disease.

作者信息

Cantin André M, Bilodeau Ginette, Larivée Pierre, Richter Martin V

机构信息

Respiratory Division, Department of Medicine, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec.

出版信息

Clin Invest Med. 2012 Jul 4;35(4):E173-81. doi: 10.25011/cim.v35i4.17145.

DOI:10.25011/cim.v35i4.17145
PMID:22863555
Abstract

PURPOSE

The purpose of this study was to determine whether plasma biomarkers reflect changes in lung function and respiratory exacerbations associated with CF lung disease.

METHODS

Plasma human leukocyte elastase/alpha1 antitrypsin complex (pHLE complex) values were measured in 28 adult CF patients and 47 healthy volunteers and correlated with forced expiratory volume (FEV1) and forced vital capacity (FVC). pHLE complexes were studied during respiratory exacerbations and after antibiotic therapy. Plasma cytokines and sialic acid were also measured.

RESULTS

pHLE complexes were increased in CF patients (p < 0.01), were inversely correlated with FEV1 (r = 0.71) and FVC (r = 0.67) and returned to normal levels after intravenous antibiotics (p < 0.001). Plasma cytokines did not correlate with lung function. Total sialic acid increased during CF respiratory exacerbations and decreased after antibiotic therapy.

CONCLUSION

Plasma sialic acid and pHLE complexes reflect clinically meaningful changes in CF lung disease. In contrast, plasma cytokine levels did not correlate with lung function.

摘要

目的

本研究的目的是确定血浆生物标志物是否反映与囊性纤维化肺病相关的肺功能变化和呼吸道加重情况。

方法

对28名成年囊性纤维化患者和47名健康志愿者测量血浆人白细胞弹性蛋白酶/α1抗胰蛋白酶复合物(pHLE复合物)值,并将其与用力呼气量(FEV1)和用力肺活量(FVC)相关联。在呼吸道加重期间和抗生素治疗后研究pHLE复合物。还测量了血浆细胞因子和唾液酸。

结果

囊性纤维化患者的pHLE复合物增加(p < 0.01),与FEV1(r = 0.71)和FVC(r = 0.67)呈负相关,静脉注射抗生素后恢复到正常水平(p < 0.001)。血浆细胞因子与肺功能无关。在囊性纤维化呼吸道加重期间总唾液酸增加,抗生素治疗后减少。

结论

血浆唾液酸和pHLE复合物反映了囊性纤维化肺病临床上有意义的变化。相比之下,血浆细胞因子水平与肺功能无关。

相似文献

1
Plasma biomarkers and cystic fibrosis lung disease.血浆生物标志物与囊性纤维化肺病
Clin Invest Med. 2012 Jul 4;35(4):E173-81. doi: 10.25011/cim.v35i4.17145.
2
Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.囊性纤维化肺部加重期治疗对全身炎症的影响。
Ann Am Thorac Soc. 2015 May;12(5):708-17. doi: 10.1513/AnnalsATS.201410-493OC.
3
Oxidative stress during acute respiratory exacerbations in cystic fibrosis.囊性纤维化急性呼吸道加重期的氧化应激
Thorax. 1999 Jun;54(6):518-23. doi: 10.1136/thx.54.6.518.
4
Galectin-3 levels in children with cystic fibrosis.半乳糖凝集素-3 在囊性纤维化患儿中的水平。
Eur J Pediatr. 2024 May;183(5):2333-2342. doi: 10.1007/s00431-024-05479-6. Epub 2024 Mar 2.
5
Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.囊性纤维化中的中性粒细胞介质、铜绿假单胞菌与肺功能障碍
J Lab Clin Med. 1993 May;121(5):654-61.
6
Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.囊性纤维化中的人中性粒细胞弹性蛋白酶和弹性蛋白酶/α1-抗蛋白酶复合物。与间质性肺病的比较及静脉注射抗生素治疗效果的评估。
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):580-5. doi: 10.1164/ajrccm/144.3_Pt_1.580.
7
Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.囊性纤维化患者痰液和呼出气冷凝液中炎症和免疫反应生物标志物的多参数生物芯片阵列分析。
Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):423-32. doi: 10.1177/039463201102400215.
8
Circulating immunoreactive interleukin-6 in cystic fibrosis.囊性纤维化患者循环中的免疫反应性白细胞介素-6
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1764-9. doi: 10.1164/ajrccm.157.6.9704086.
9
Inflammatory markers of lung disease in adult patients with cystic fibrosis.成年囊性纤维化患者肺部疾病的炎症标志物
Pediatr Pulmonol. 2007 Mar;42(3):256-62. doi: 10.1002/ppul.20563.
10
Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.痰液克拉拉细胞蛋白浓度与囊性纤维化患者的肺部加重相关。
J Cyst Fibros. 2015 May;14(3):334-40. doi: 10.1016/j.jcf.2014.10.002. Epub 2014 Oct 23.

引用本文的文献

1
Optimizing synthetic cystic fibrosis sputum media for growth of non-typeable Haemophilus influenzae.优化合成性囊性纤维化痰液培养基以促进不可分型流感嗜血杆菌生长。
Access Microbiol. 2025 Jun 20;7(6). doi: 10.1099/acmi.0.000979.v3. eCollection 2025.
2
Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review.用于预测和诊断囊性纤维化肺部加重的代谢组学生物标志物:一项系统综述
Front Pediatr. 2022 May 31;10:896439. doi: 10.3389/fped.2022.896439. eCollection 2022.
3
Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity.
利用集中的生物库样本进行囊性纤维化肺病严重程度的生物标志物研究。
J Cyst Fibros. 2020 Jul;19(4):632-640. doi: 10.1016/j.jcf.2019.12.007. Epub 2019 Dec 20.
4
The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.MAG-DHA 纠正囊性纤维化患者 AA/DHA 失衡的疗效。
Mar Drugs. 2018 May 26;16(6):184. doi: 10.3390/md16060184.
5
Biomarkers for cystic fibrosis drug development.用于囊性纤维化药物研发的生物标志物。
J Cyst Fibros. 2016 Nov;15(6):714-723. doi: 10.1016/j.jcf.2016.10.009. Epub 2016 Oct 27.
6
Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.阿塞比司他的I期研究:囊性纤维化患者的生物标志物反应与安全性
Clin Transl Sci. 2017 Jan;10(1):28-34. doi: 10.1111/cts.12428. Epub 2016 Nov 2.